Sarcoma botryoides surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Sarcoma botryoides Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Sarcoma botryoides from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratpory Tests

Pelvic X Ray

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sarcoma botryoides surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sarcoma botryoides surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sarcoma botryoides surgery

CDC on Sarcoma botryoides surgery

Sarcoma botryoides surgery in the news

Blogs on Sarcoma botryoides surgery

Directions to Hospitals Treating Sarcoma botryoides

Risk calculators and risk factors for Sarcoma botryoides surgery

## Overview[edit | edit source]

Sarcoma botryoides, also known as embryonal rhabdomyosarcoma, is a type of rhabdomyosarcoma in the vagina of young girls, typically younger than 8. The name comes from the gross appearance of "grape bunches" (botryoid in Greek).

## Surgery[edit | edit source]

The disease used to be uniformly fatal, with a 5-year survival rate between 10 to 35% (Piver and Rose, 1988)[1]. As a result, treatment was radical surgery[2] [3]. New multidrug chemotherapy regimens with or without radiation therapy are now used in combination with less radical surgery with good results, although outcome data are not yet available (Rotmensch and Yamada, 2003)[4][5].

## References[edit | edit source]

1. ↑ Piver M, Rose P (1988). "Long-term follow-up and complications of infants with vulvovaginal embryonal rhabdomyosarcoma treated with surgery, radiation therapy, and chemotherapy". Obstet Gynecol. 71 (3 Pt 2): 435–7. PMID 3347430.
2. ↑ Hilgers R (1975). "Pelvic exenteration for vaginal embryonal rhabdomyosarcoma: a review". Obstet Gynecol. 45 (2): 175–80. PMID 1090863.
3. ↑ Rahaman, J and Cohen, CJ. Gynecologic Sarcomas. in Holland-Frei Cancer Medicine - 6th Ed. Kufe, DW et al editors. BC Decker Inc, Hamilton, Ontario, 2003.
4. ↑ Rotmensch, J and Yamada, SD. Neoplasms of the Vulva and Vagina. in Holland-Frei Cancer Medicine - 6th Ed. Kufe, DW et al editors. BC Decker Inc, Hamilton, Ontario, 2003
5. ↑ Reynolds E, Logani S, Moller K, Horowitz I (2006). "Embryonal rhabdomyosarcoma of the uterus in a postmenopausal woman. Case report and review of the literature". Gynecol Oncol. 103 (2): 736–9. PMID 16684558.CS1 maint: Multiple names: authors list (link)

de:Sarcoma botryoides

Template:WikiDoc Sources